Bernstein initiates Puma stock with Outperform rating amid brand cycle trough

Bernstein initiated coverage on Puma SE with an Outperform rating and EUR24.00 price target, citing the sportswear company as undervalued and at an inflection point, despite a 25% stock decline and expected revenue contraction. The firm believes Puma is nearing a brand cycle trough, with its new CEO actively resetting expectations, and sees an asymmetric risk/reward profile over the next 6-9 months. This bullish outlook contrasts with JPMorgan's recent downgrade to Underweight due to concerns over the turnaround's early stage, inventory, and distribution, while UBS upgraded to Neutral, partly due to reports of Artemis considering options for its 29% stake, highlighting diverse analyst sentiment and potential catalysts for the stock.

Analysis

Puma SE (ETR:PUM) is currently the subject of sharply divergent analyst opinions, signaling a period of high uncertainty and potential volatility. Bernstein has initiated coverage with a bullish "Outperform" rating and a EUR24.00 price target, positing that the company is at a strategic inflection point. This view is predicated on the belief that Puma is near the trough of its brand cycle following a 25% stock price decline over six months, creating an asymmetric risk/reward profile. Bernstein highlights the new CEO's decisive actions to reset expectations and points to underlying strengths like strong brand heritage and traction in key categories. This optimism is directly countered by JPMorgan's recent downgrade to "Underweight" with a EUR16.00 price target. JPMorgan expresses caution about the turnaround being in its nascent stages, citing risks associated with managing excess inventory and improving distribution. Adding another layer, UBS upgraded the stock from "Sell" to "Neutral" with a EUR20.90 target, not on operational strength but on the potential for a strategic shift, as major shareholder Artemis (29% stake) is reportedly considering options for its holding. This mixed sentiment is underscored by data indicating downward earnings revisions and an expected revenue decline this year, painting a complex picture of a potential turnaround story facing significant near-term headwinds and execution risks.

Key Decisions for Investors

• Investors with a higher risk appetite may consider the 25% stock decline and Bernstein's 'Outperform' rating as an opportunity to build a position at a cyclical trough, betting on a successful turnaround and the described asymmetric risk/reward profile.
• Given JPMorgan's concerns about execution risk and excess inventory, more conservative investors should wait for tangible evidence of operational improvement from the new CEO over the next 6-9 months before committing capital.
• All investors should closely monitor any developments regarding the 29% stake held by Artemis, as a potential sale or strategic review could serve as a major short-term stock catalyst, independent of the company's fundamental performance.
• It is crucial to track management's ability to generate 'brand heat' and invest in sports heritage, as success in these areas will be a leading indicator for validating the long-term bull thesis against the backdrop of declining revenue forecasts.